Research graph
References from Aspirin in Primary Prevention: A Case for Selective Use. Local targets link to admitted publications; unresolved targets remain external evidence.
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: a report of the American heart Association/American College of Cardiology Joint Committee on clinical practice guidelines
10.1161/cir.0000000000001168 · 2023 · External reference
2021 ESC guidelines on cardiovascular disease prevention in clinical practice: developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies with the special contribution of the European Association of Preventive Cardiology (EAPC)
10.1093/eurheartj/ehab484 · 2021 · External reference
Final report on the aspirin component of the ongoing Physicians' Health Study
10.1056/nejm198907203210301 · 1989 · External reference
10.1186/s41073-019-0064-8 · 2019 · Admitted local publication
Beyond PICO: the SPIDER tool for qualitative evidence synthesis
10.1177/1049732312452938 · 2012 · External reference
Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA)
10.1161/circulationaha.105.580696 · 2006 · External reference
2019 ACC/AHA guideline on the primary prevention of cardiovascular disease
2019 · External reference
Aspirin use to prevent cardiovascular disease: US preventive services task force recommendation statement
10.1001/jama.2022.5207 · 2022 · External reference
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial
10.1016/s0140-6736(18)31924-x · 2018 · External reference
Effect of aspirin on cardiovascular events and bleeding in the healthy elderly
10.1056/nejmoa1805819 · 2018 · External reference
Effects of aspirin for primary prevention in persons with diabetes mellitus
10.1056/nejmoa1804988 · 2018 · External reference
Baseline characteristics of participants in the ASPREE (ASPirin in reducing events in the elderly) study
10.1093/gerona/glw342 · 2017 · External reference
Association of aspirin use for primary prevention with cardiovascular events and bleeding events: a systematic review and meta-analysis
10.1001/jama.2018.20578 · 2019 · External reference
Aspirin for primary prevention of cardiovascular events
10.1016/j.jacc.2019.03.501 · 2019 · External reference
Efficacy and safety of aspirin for primary prevention of cardiovascular events: a meta-analysis and trial sequential analysis of randomized controlled trials
10.1093/eurheartj/ehy813 · 2019 · External reference
Quantification of coronary artery calcium using ultrafast computed tomography
10.1016/0735-1097(90)90282-t · 1990 · External reference
Coronary artery calcium and long-term risk of death, myocardial infarction, and stroke: the walter reed cohort study
10.1016/j.jcmg.2017.09.003 · 2018 · External reference
Impact of plaque burden versus stenosis on ischemic events in patients with coronary atherosclerosis
10.1016/j.jacc.2020.10.021 · 2020 · External reference
When does a calcium score equate to secondary prevention?
2023 · External reference
Independent association of lipoprotein(a) and coronary artery calcification with atherosclerotic cardiovascular risk
10.1016/j.jacc.2021.11.058 · 2022 · External reference
Impact of statins on cardiovascular outcomes following coronary artery calcium scoring
10.1016/j.jacc.2018.09.051 · 2018 · External reference
2019 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines
2019 · External reference
2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
10.1016/j.atherosclerosis.2019.08.014 · 2019 · External reference
The National Lipid Association scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reduction
10.1016/j.jacl.2020.12.005 · 2021 · External reference
Clinical indications for coronary artery calcium scoring in asymptomatic patients: expert consensus statement from the Society of Cardiovascular Computed Tomography
10.1016/j.jcct.2017.02.010 · 2017 · External reference
The use of coronary artery calcium testing to guide aspirin utilization for primary prevention: estimates from the multi-ethnic study of atherosclerosis
10.1161/circoutcomes.113.000690 · 2014 · External reference
Coronary artery calcium for personalized allocation of aspirin in primary prevention of cardiovascular disease in 2019: the MESA study (Multi-Ethnic study of atherosclerosis)
10.1161/circulationaha.119.045010 · 2020 · External reference
Value of coronary artery calcium scanning in association with the net benefit of aspirin in primary prevention of atherosclerotic cardiovascular disease
10.1001/jamacardio.2020.4939 · 2021 · External reference
Carotid ultrasound‐based plaque score for the allocation of aspirin for the primary prevention of cardiovascular disease events: the multi‐ethnic study of atherosclerosis and the atherosclerosis risk in communities study
10.1161/jaha.123.034718 · 2024 · External reference
Aspirin and cardiovascular risk in individuals with elevated lipoprotein(a): the multi-ethnic study of atherosclerosis
10.1161/jaha.123.033562 · 2024 · External reference
Aspirin use for primary prevention among US adults with and without elevated Lipoprotein(a)
10.1016/j.ajpc.2024.100674 · 2024 · External reference
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
10.1056/nejm199704033361401 · 1997 · External reference
Measurement and application of incidentally detected coronary calcium
10.1016/j.jacc.2024.01.039 · 2024 · External reference
2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines
2021 · External reference
Prognostic and therapeutic implications of statin and aspirin therapy in individuals with nonobstructive coronary artery disease
10.1161/atvbaha.114.304351 · 2015 · External reference
Association of carotid artery plaque with cardiovascular events and incident coronary artery calcium in individuals with absent coronary calcification: the MESA
10.1161/circimaging.120.011701 · 2021 · External reference
CAC-DRS: coronary artery calcium data and reporting system. An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT)
10.1016/j.jcct.2018.03.008 · 2018 · External reference
Polymorphism in the apolipoprotein(a) gene, plasma lipoprotein(a), cardiovascular disease, and low-dose aspirin therapy
10.1016/j.atherosclerosis.2008.07.019 · 2009 · External reference
Aspirin for primary prevention of cardiovascular events in relation to Lipoprotein(a) genotypes
10.1016/j.jacc.2022.07.027 · 2022 · External reference
C-Reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
10.1056/nejm200003233421202 · 2000 · External reference
Inflammation and cholesterol as predictors of cardiovascular events among 13 970 contemporary high-risk patients with statin intolerance
10.1161/circulationaha.123.066213 · 2024 · External reference
Rosuvastatin to prevent vascular events in men and women with elevated C-Reactive protein
10.1056/nejmoa0807646 · 2008 · External reference
Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials
10.1016/s0140-6736(23)00215-5 · 2023 · External reference
